Professor, Medicine, University of Miami School of Medicine
Internal Medicine
Dr. Barry J. Materson, MD
|
|
Give Review
Barry Materson practices Internal Medicine. He attended University of Miami Miller School of Medicine. University of Miami Miller School of Medicine is ranked 45/0 in Research/PrimaryCare. He over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Whos Who in Medicine and Healthcare". Barry J. Materson, MD has written publications. He has 100 publications published with PubMed. The lastest publication is: 'Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Gr...'
Publications
- Management of Hypertension in hospitalized patients.
- Effects of Nebivolol Versus Metoprolol on Sodium Sensitivity and Renal Sodium Handling in Hypertensive Hispanic Postmenopausal Women.
- Clinical Practice Guidelines for the Management of Hypertension in the Community: A Statement by the American Society of Hypertension and the International Society of ...
- Clinical Practice Guidelines for the Management of Hypertension in the Community. A Statement by the American Society of Hypertension and the International Society of ...
- Hypertension in peritoneal dialysis patients: epidemiology, pathogenesis, and treatment.
- Hypertension guidelines: a major reappraisal critically examines the available evidence.
- When and how to use self (home) and ambulatory blood pressure monitoring.
- Treatment of Hypertension in patients with diabetes--an update.
- ASH position paper: dietary approaches to lower blood pressure.
- Combination therapy in Hypertension.
- Definition and classification of Hypertension: an update.
- Easily "curable" anxiety-induced Hypertension.
- Inherent inaccuracies and potential utility of race/ethnicity labeling in the treatment of Hypertension.
- Dietary sodium chloride reduction by means of a salt substitute in China.
- Historical perspective of low- vs. high-dose diuretics.
- ASH Committee on Committees: Much Work in Progress.
- Enhancing dosage flexibility in combination therapy.
- Combination therapy with renin-angiotensin system blockers: will amlodipine replace hydrochlorothiazide?
- How "pre" is preHypertension?
- Variability in response to antiHypertensive drugs.
- Nonpharmacologic therapy for Hypertension: does it really work?
- PreHypertension: an important preventive medicine concept--or marketing ploy?
- Expanding the definition and classification of Hypertension.
- Treating stage 2 Hypertension.
- David Ayman, MD: an early investigator of clinical Hypertension.
- Variability in response to antiHypertensive drug treatment.
- High blood pressure in African Americans.
- Blood pressure-independent impact of antihypertensive agents on cardiovascular and renal Disease.
- Effects of severe, uncontrolled Hypertension on endothelial activation: soluble vascular cell adhesion molecule-1, soluble intercellular adhesion molecule-1 and von Wi...
- Captopril is an unlikely cause of nephrotic syndrome.
- Pulse pressure changes with six classes of antiHypertensive agents in a randomized, controlled trial.
- Combination therapy as the initial drug treatment for Hypertension: when is it appropriate?
- Ventricular and myocardial function following treatment of Hypertension.
- Placebo-associated blood pressure response and adverse effects in the treatment of Hypertension: observations from a Department of Veterans Affairs Cooperative Study.
- Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with Hypertension in the United States. Departme...
- Accessing data from external centralized sources to enhance analysis of a completed clinical trial.
- Reducing the risk of malpractice claims.
- Clinical presentation and management of patients with uncontrolled, severe Hypertension: results from a public teaching hospital.
- Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with Hypertension. Department of Veterans Affairs Coo...
- Effects of antiHypertensive single-drug therapy on heart rate. Department of Veterans Affairs Cooperative Study Group on AntiHypertensive Agents.
- Reducing hypertension-associated cardioRenal risk: the role of heart rate, left ventricular hypertrophy regression, and renoprotection.
- Prospective, double-blind, seemingly ignored clinical trials.
- Age-race subgroup compared with renin profile as predictors of blood pressure response to antiHypertensive therapy. Department of Veterans Affairs Cooperative Study Gr...
- Will angiotensin converting enzyme genotype, receptor mutation identification, and other miracles of molecular biology permit reduction of NNT?
- Disease management, pharmacoeconomics, and molecular biology: tools for prevention of hypertensive complications.
- Effect of single-drug therapy on reduction of left atrial size in mild to moderate Hypertension: comparison of six antihypertensive agents.
- Comparison of effects of antiHypertensive drugs on heart rate: changes from baseline by baseline group and over time. Department of Veterans Affairs Cooperative Study ...
- Safety of long-acting dihydropyridine calcium channel blockers in Hypertensive patients.
- Systolic function in Hypertensive men with concentric remodeling.
- Proteinuria in mild to moderate Hypertension: results of the VA cooperative study of six antihypertensive agents and placebo. Department of Veterans Affairs Cooperativ...
- Diuretics, potassium, and ventricular ectopy.
- Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate Hypertension: comparison of six antihypertensive agents. The Department of Vete...
- Acetaminophen-related acute Renal failure without fulminant liver failure.
- Left atrial size in Hypertensive men: influence of obesity, race and age. Department of Veterans Affairs Cooperative Study Group on AntiHypertensive Agents.
- Prevention of diabetic nephropathy.
- Hypertension in Haitians: results of a pilot survey of a public teaching hospital multispecialty clinic.
- Lessons from combination therapy in Veterans Affairs Studies. Department of Veterans Affairs Cooperative Study Group on antiHypertensive agents.
- Comparison of plasma lipid and lipoprotein profiles in Hypertensive black versus white men. Department of Veterans Affairs Cooperative Study Group on AntiHypertensive ...
- Lessons on the interaction of race and antiHypertensive drugs from the VA cooperative study group on antiHypertensive agents.
- Results of combination anti-Hypertensive therapy after failure of each of the components. Department of Veterans Affairs Cooperative Study Group on Anti-Hypertensive A...
- ACE inhibitors as a shield against diabetic nephropathy.
- Single-drug therapy for Hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on An...
- [The cost of quality assurance].
- Alterations in heart rate variability and its circadian rhythm in hypertensive patients with left ventricular hypertrophy free of coronary artery Disease.
- Correction: single-drug therapy for Hypertension in men.
- Angiotensin-converting enzyme inhibitors in Hypertension. A dozen years of experience.
- Fluid and electrolyte disorders in congestive Heart failure.
- Isolated systolic Hypertension. Another disincentive to treatment is removed.
- Importance of obesity, race and age to the cardiac structural and functional effects of Hypertension. The Department of Veterans Affairs Cooperative Study Group on Ant...
- Modern strategies to prevent coronary sequelae and stroke in Hypertensive patients differ from the JNC V Consensus Guidelines.
- Calcium channel blockers. Is it time to split the lump?
- Department of veterans Affairs single-drug therapy of Hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antih...
- Response to a second single antihypertensive agent used as monotherapy for Hypertension after failure of the initial drug. Department of Veterans Affairs Cooperative S...
- Complicated Hypertension.
- Laxative abuse syndrome.
- Insights into intraRenal sites and mechanisms of action of diuretic agents.
- Potassium and diuretic-induced ventricular arrhythmias in ambulatory Hypertensive patients.
- Comparison of propranolol or hydrochlorothiazide alone for treatment of Hypertension. III. Evaluation of the renin-angiotensin system.
- Slow-release oxprenolol compared with oxprenolol in Hypertensive patients: a multicenter clinical trial.
- Risk of cardiac arrhythmias in relation to potassium imbalance.
- Monotherapy of Hypertension with angiotensin-converting enzyme inhibitors.
- Angiotensin converting enzyme inhibitors in the treatment of Hypertension.
- Short-term versus long-term changes in serum cholesterol with thiazide diuretics alone.
- LSD "mainlining". A new hazard to health.
- Inulin labeled with chromium 51 for determination of glomerular filtration rate.
- The glomerulopathies.
- Generalized burning paresthesia due to intravenous furosemide.
- Measurement of glomerular filtration rate.
- Diuretic drug therapy of edema.
- Oral metolazone: effects on urine composition in water-loaded normal man.
- AntiHypertensive effects of metolazone (zaroxolyn).
- Comparative effects of diltiazem and hydrochlorothiazide in blacks with systemic Hypertension.
- Diuretic-associated Hypokalemia.
- Black/white differences in response to antiHypertensive therapy.
- Monotherapy with labetalol compared with propranolol. Differential effects by race.
- PseudoHypertension: a diagnostic dilemma.
- A multicenter, randomized, double-blind dose-response evaluation of step-2 guanfacine versus placebo in mild to moderate Hypertension.
- Use of the anion gap in clinical medicine.
- Geriatric Hypertension: the growing use of calcium-channel blockers.
Schools
University Of Miami School Of Medicine
Los Angeles Co Genl Hospital
Jackson Memorial Hospital
Miami Va Hospital
Conditions Treated
- Chronic Kidney Diseases
- Congenital Cystic Kidney Disease
- End-Stage Renal Disease
- Gout
- View All
Doctors Specialties
- Nephrology
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Whos Who in Medicine and Healthcare
Education
-
Jackson Memorial Hospital - Jackson Health System -
University of Southern California - LAC+USC Medical Center -
University of Miami Miller School of Medicine
Hospital
-
University of Miami Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Adam G. Golden, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark R. Keller, MD |
|
|
Dr. Osvaldo L. Rodriguez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rene A. Parraga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zeina C. Hannoush, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald S. Lubetsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Warren L. Kupin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Preston, MD |
|
|
Dr. Anne Marie V. Miles, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Angela B. Gonzalez, RPT
This Doctor is OpenDoctor Recommended.
|